Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
REDEFINE 4: The Tirzepatide Test The results that attracted the greatest market attention came from REDEFINE 4, an 84-week open-label Phase 3 trial reported in February 2026, in which CagriSema was pitted directly against tirzepatide 15 mg, the highest approved dose of Eli Lillys Zepbound
PACK SIZE: 30 SERVINGS | SERVING SIZE-1 GUMMIE
Individuals with Obesity or Type 2 Diabetes: Likely to benefit from both the metabolic and alcohol-reducing effects
Always be upfront about what you do and don't know
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
